Our partnerships with the pharmaceutical industry

The support we received in FY21 is detailed below.

Unless otherwise stated, these companies played no part in the organisation, design, or content of any of the work listed.

For more information on how and why we work with the industry, read our Policy on working with pharma.

• £15,000: Reducing delays to diagnosis – research undertaken by UCL
• £30,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £480: Advisory board
• £420: Haematology summit

• £11,563: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £9,824: Employability support for staff made redundant in restructure
• £14,112: COVID-19 support 2021
• £360: Advisory board
• £360: Advisory board

• £7,500: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £56,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £11,568: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £53,889: Clinical Trials Support Service
• £600: Advisory board

• £11,563: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £39,000: Coalition – Clinical Trials

• £11,563: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £53,889: Clinical Trials Support Service

• £53,889: Clinical Trials Support Service

• £11,563: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £10,000: Reducing delays to diagnosis – research undertaken by UCL
• £150: Advisory board
• £450: Patient interviews

• £5,000: Patient information

• £5,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £5,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £7,024: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £10,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £3,602: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £7,961: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic
• £10,000: Psychological support research

• £1,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £11,563: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £5,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £10,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £9,437: Befriending service

£1,000: Emergency appeal – supporting people with blood cancer during the COVID-19 pandemic

• £7,500: Support services 2021